“Looking at the banking index, despite today’s correction, it’s hovering around a rising trendline support near the 56,500 zone. So, if we get a positive closing, that would be encouraging and could signal a reversal,” says Sneha Seth, Angel One.Definitely a very dull Friday and a weak end to the week as well. But how … Read more
Shares of pharmaceutical companies rallied up to 4% on Tuesday as investors expect that US President Donald Trump‘s executive order will have minimal impact on US generics. Dr Reddy’s shares were up around 4% while Granules, Glenmark, Lupin, Divi’s Lab, and Aurobindo Pharma were trading around 3% higher. Nifty Pharma index itself rose around 2% … Read more
Dr Reddy’s Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus Rs 1,307 crore reported in the year ago period. The pharma major’s revenue from operations in the March-ended quarter stood at Rs 8,506 crore, which was up 20% versus Rs 7,083 crore in the corresponding … Read more
The fourth quarter earnings season is picking up momentum and on Friday as many as 68 companies will announce their quarterly numbers. Key earnings to watch out include from Swiggy and Dr Reddy’s. Apart from the above, ABB India, Aditya Consumer Marketing, Bank of India, Birla Corp, Dhanlaxmi Bank, FGP, GRP, KPR Mill, Lloyds Enterprises, … Read more
“So, the bias is positive and the breakout on the index will happen above 22,750 on Nifty on the upside and on the downside the texture could deteriorate only if we break 22,100,” says Aditya Arora, Adlytick.Nifty has been sideways for the last five to six consecutive sessions. When are we going to really pick … Read more
Domestic markets extended their rebound, gaining nearly half a percent on Tuesday, supported by a recovery in global indices. In today’s trade, shares of HDFC Bank, Vodafone Idea, Dr Reddy’s, RIL, IndiGo among others will be in focus due to various news developments. Vodafone IdeaVodafone Idea has in recent weeks approached state-owned lenders Power Finance … Read more
Hyderabad: Dr Reddy’s Laboratories Ltd has introduced its direct-to-consumer (D2C) online platform, ‘Celevida Wellness,’ catering specifically to diabetes patients through its wholly-owned subsidiary, Svaas Wellness Limited. Celevida Wellness aims to serve as a comprehensive solution for personalised care for individuals with Type 2 diabetes and those at risk of developing it, said the company. The … Read more
Leading pharma players Cipla and Dr Reddy’s will announce their second-quarter results on October 27. Here’s a brief look at what to expect from these companies in the September quarter. CiplaCipla could deliver healthy growth of 5% in the Indian business in the second quarter, but the US business is likely to witness pressure on … Read more
Mumbai: A staggering amount of wealth was created by the upper echelons of corporate India over the last two years even as tough economic conditions loom large over the payouts of the broader employee base. A total of about ₹8,717.65 crore was potentially made over the last two fiscals by the senior-to-top management of 12 … Read more
NEW DELHI: As leaders of the world’s largest economies gather in New Delhi this week for the G20 Summit, a global consensus is emerging among investors recognising the potential of India’s economic and industrial prowess, making several sectors attractive to global investors. We reached out to money managers to filter out P20 (20 portfolio) stocks … Read more